BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37920148)

  • 21. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
    Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
    Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
    J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
    Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
    Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications.
    Hodgson A; Amemiya Y; Seth A; Cesari M; Djordjevic B; Parra-Herran C
    Mod Pathol; 2017 Nov; 30(11):1633-1641. PubMed ID: 28731050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.
    Chang MC; Nevadunsky NS; Viswanathan AN; Crum CP; Feltmate CM
    Int J Gynecol Pathol; 2010 Jan; 29(1):88-92. PubMed ID: 19952931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
    Park KJ
    Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma.
    Zhou F; Chen H; Li M; Strickland AL; Zheng W; Zhang X
    Am J Surg Pathol; 2022 Mar; 46(3):300-308. PubMed ID: 35175967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists.
    Parra-Herran C; Taljaard M; Djordjevic B; Reyes MC; Schwartz L; Schoolmeester JK; Lastra RR; Quick CM; Laury A; Rasty G; Nucci MR; Howitt BE
    Mod Pathol; 2016 Aug; 29(8):879-92. PubMed ID: 27174588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
    Chen L; Lucas E; Zhang X; Liu Q; Zhuang Y; Lin W; Chen H; Zhou F
    Histopathology; 2022 Jan; 80(2):338-347. PubMed ID: 34455625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
    Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
    Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Involvement of the Adnexa and Uterine Corpus by Carcinomas of the Uterine Cervix: A Detailed Morphologic Description.
    Reyes C; Murali R; Park KJ
    Int J Gynecol Pathol; 2015 Nov; 34(6):551-63. PubMed ID: 26166722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 Cases.
    Lu B; Shi H; Shao Y; Xu J
    Int J Gynecol Pathol; 2022 Jul; 41(4):356-365. PubMed ID: 34347666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytology and curetting diagnosis of endocervical adenocarcinoma.
    Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
    J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded study on the risk of lymphovascular space invasion and lymph node metastasis of endocervical adenocarcinoma using Pattern Classification: a single-centre analysis of 213 cases.
    Xu H; Pan H; Wang Y; Zhang J
    Pathology; 2019 Oct; 51(6):570-578. PubMed ID: 31445810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.
    Abozina A; Singh N; Blake C
    Int J Gynecol Pathol; 2020 May; 39(3):296-300. PubMed ID: 31033802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.